Skip to content
Open Menu
Search for:
News & events
Insight & resources
Facilities
Careers
Contact
Drug substance
Back to main menu
Drug substance
Custom development
Process development & validation
Analytical development & validation
Custom manufacturing
Technology transfer
Manufacturing capabilities
Quality & regulatory
Environment, health & safety
Generic APIs
Product catalogue
Controlled substances
High potency APIs
Specialist technologies
Biocatalysis
Continuous flow
Controlled substances
Crystallization process development
High potency APIs
Solid state science
Material characterization
Drug product
Back to main menu
Drug product
Custom development
Formulation development
Analytical development & validation
Clinical supply
Custom manufacturing
Technology transfer
Manufacturing capabilities
Quality & regulatory
Environment, health & safety
Packaging
Conventional dosage forms
Solid dose
Semi-solid dose
Liquids
Specialized dosage forms
Fixed-dose combinations
Pediatric
Bi-layer tablets
Stick packs
Topicals
Controlled substances
Sterile & non-sterile
Solid state science
Material characterization
Analytical services
Back to main menu
Analytical services
Compendial testing
Microbiology
Cleanroom services
Release & QC testing
Extractables/leachables studies
Stability storage
Method development & validation
Material characterization
Elemental impurities
Impurity isolation, identification & characterization
Reference standard qualification
Bioanalytical & biopharmaceutical analysis
Biopharmaceutical Testing
Open Search
News & events
News
Search news
Post date
Post Date
Tags
Tags
All Tags
About (1)
analytical services (18)
APIs (1)
biocatalysis (1)
Cambrex (3)
Careers (1)
case study (20)
cGMP (1)
Chemistry (1)
Company (2)
Compounds (1)
Continuous flow (3)
Corporate Brochure (1)
Custom Development (1)
Development (1)
Drug product (12)
Drug substance (18)
Facilities (1)
HPAPIs (1)
information sheet (11)
Literature (4)
Manufacturing (1)
Meet our experts (1)
Opioids (1)
Resources (3)
Small Molecule (1)
Video (1)
Webcasts (1)
Webinar (3)
whitepaper (4)
By author
By Author
All Authors
Cambrex (99)
Dan McGinn (1)
Hannah McLachlan (36)
Leanne Buffery (2)
Natalee Campbell (3)
Advanced search
Year:
2022
1 Sep 2022
Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina
1 Jun 2022
Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific
12 Apr 2022
Cambrex Completes Large-Scale US API Expansion
1 Mar 2022
Cambrex Expands Biopharmaceutical Services Business
8 Feb 2022
Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year
11 Jan 2022
Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity
Skip to content Open Menu